MRT (TSE:6034) ROCE %: -8.26% (As of Mar. 2026)


TSE:6034 MRT Inc TSE:6034
63 GF Score
Price 円630.00
GF Value 円635.93
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is MRT ROCE %?

MRT TSE:6034 63 ROCE % is -8.26% as of Mar. 2026. GuruFocus rates TSE:6034 with a GF Score™ of 63/100 and a GF Value™ of 円635.93 (Fairly Valued). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. MRT's annualized ROCE % for the quarter that ended in Mar. 2026 was -8.26%.

MRT  (TSE:6034) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

MRT ROCE % Related Terms

MRT ROCE % Historical Data

* Premium members only.

The historical data trend for MRT's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MRT ROCE % Chart

MRT Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 48.11 76.17 17.20 -6.14 2.32

MRT Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.80 22.39 0.47 -1.24 -8.26
TSE:6034
63GF Score
MRT Inc TSE:6034
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MRT ROCE % Calculation

MRT's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=124.903/( ( (6745.562 - 1270.995) + (6477.632 - 1206.091) )/ 2 )
=124.903/( (5474.567+5271.541)/ 2 )
=124.903/5373.054
=2.32 %

MRT's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-429.868/( ( (6477.632 - 1206.091) + (6203.141 - 1065.74) )/ 2 )
=-429.868/( ( 5271.541 + 5137.401 )/ 2 )
=-429.868/5204.471
=-8.26 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -8.26% mean?
MRT (TSE:6034) has a ROCE % of -8.26% as of Mar. 2026.
Is MRT's ROCE % too high?
MRT's current ROCE % is -8.26%. Overall, MRT has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does MRT's ROCE % compare to HCA and THC?
MRT's ROCE % of -8.26% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 646 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MRT's current ROCE % is -8.26%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MRT stock overvalued right now?
Based on GuruFocus' analysis, MRT (TSE:6034) is currently considered Fairly Valued. The stock's GF Value™ is 円635.93, compared to a current price of 円630.00 — trading 0.9% below its estimated fair value. The current ROCE % is -8.26%. MRT's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For MRT (TSE:6034), the current ROCE % is -8.26% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MRT (TSE:6034) Overvalued in 2026?

Based on GuruFocus' analysis, MRT stock appears to be undervalued. The current stock price of 円630.00 is trading 0.9% below its estimated GF Value™ of 円635.93. GuruFocus considers MRT to be Fairly Valued.

Key valuation signals for TSE:6034:

  • ROCE %: -8.26%
  • GF Value™: 円635.93 vs. price of 円630.00 (0.9% below fair value)
  • GF Score™: 63/100 with 4 warning signs

No single metric tells the full story. See the TSE:6034 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MRT Business Description

Address 1-18-2 Jinnan, 3rd Floor, Frame Jinnanzaka, Shibuya-ku, Tokyo, JPN, 150-0041
MRT Inc engages in the business of medical personnel placement services through the Internet. It provides part-time and full-time physician referral services through the physician referral site, as well as part-time job referral, job change introduction services to nurses, pharmacists, clinical laboratory technicians, clinical engineers, and radiologists. Further, the company engages in the research and development of analytical and analytical methods for various biological samples, such as microorganisms, blood, proteins, and genes; and research and development, manufacture, and sale of medical and medical examination equipment, and analytical instruments.
63GF Score

Get the complete analysis for TSE:6034

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円630.00
Price
円635.93
GF Value